MetaCap

eXoZymes Earnings

NASDAQ: EXOZHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.91-0.475 (-14.05%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

eXoZymes earnings summary

In its most recent report on Nov 13, 2026 (Sep/2026), EXOZ posted EPS of $-0.24. Across the last 10 reports, EXOZ shares moved an average of 16.0% (in either direction) in the first trading session after results, rising 6 times and falling 4 times.

Summary generated from market data by MetaCap's automated system. Methodology

EXOZ earnings history

eXoZymes reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Nov 13, 2026—$-0.24—-24.2%
Nov 12, 2026—$-0.27—-24.2%
Aug 13, 2026—$-0.33—+22.9%
May 14, 2026—$-0.28—+1.6%
Mar 30, 2026—$-0.32—+33.9%
Nov 13, 2025—$-0.27—+4.8%
Aug 12, 2025—$-0.28—-4.0%
May 12, 2025—$-0.22—-0.9%
Mar 31, 2025—$-0.24—+9.5%
Nov 12, 2024—$-0.27—+34.0%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related